Qube Research & Technologies (QRT)
OPTN

Qube Research & Technologies (QRT)’s OptiNose OPTN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,808
Closed -$28.2K – 3730
2024
Q3 		$28.2K Sell
2,808
-7,095
-72% -$103K ﹤0.01% 2938
2024
Q2 		$154K Buy
+9,903
New +$166K ﹤0.01% 2502
2023
Q2 		– Sell
-3,132
Closed -$90.7K – 2826
2023
Q1 		$90.7K Sell
3,132
-304
-9% -$8.09K ﹤0.01% 2145
2022
Q4 		$95.3K Sell
3,436
-813
-19% -$30.9K ﹤0.01% 2016
2022
Q3 		$233K Buy
4,249
+972
+30% +$53.4K ﹤0.01% 1718
2022
Q2 		$180K Buy
+3,277
New +$121K ﹤0.01% 1751

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OPTN Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 2,808 shares — an estimated $28.2K sold.

Qube Research & Technologies (QRT) first reported a position in OPTN in Q2 2022 and held it in 6 quarters. The position peaked at $233K in Q3 2022. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,808 OptiNose shares in Q4 2024, an estimated $28.2K.
  • Qube Research & Technologies (QRT) first reported a position in OptiNose in Q2 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s OptiNose position peaked at $233K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.